natgillin/translations-raw huggingface dataset:
The payment of the financial contribution should be subject to the condition that the surveillance study programmes planned have actually been carried out and that the authorities supply all the necessary information to the Commission and to the EU reference laboratory for bee health.
Plačilo finančnega prispevka se izvede pod pogojem, da so se načrtovani programi študij spremljanja dejansko izvedli in da pristojni organi zagotovijo Komisiji in referenčnemu laboratoriju EU za zdravstveno varstvo čebel vse potrebne informacije.
The Union shall grant Belgium, Denmark, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Poland, Portugal, Slovakia, Finland, Sweden and the United Kingdom financial assistance for their surveillance study programmes on honeybee colony losses.
Unija odobri Belgiji, Danski, Nemčiji, Estoniji, Grčiji, Španiji, Franciji, Italiji, Latviji, Litvi, Madžarski, Poljski, Portugalski, Slovaški, Finski, Švedski in Združenemu kraljestvu finančno pomoč za programe študij spremljanja izgub čebeljih kolonij.
shall be at the rate of 70 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the surveillance study programmes on honeybee colony losses and specified in Annex I for the period from 1 April 2012 to 30 June 2013;
znaša 70 % upravičenih stroškov, nastalih v državah članicah iz odstavka 1 za programe študij spremljanja izgub čebeljih kolonij in določenih v Prilogi I za obdobje od 1. aprila 2012 do 30. junija 2013;
EUR 62876 for Belgium;
62876 EUR za Belgijo;
EUR 192688 for Denmark;
192688 EUR za Dansko;
EUR 294230 for Germany;
294230 EUR za Nemčijo;
EUR 66637 for Estonia;
66637 EUR za Estonijo;
EUR 109931 for Greece;
109931 EUR za Grčijo;
EUR 205050 for Spain;
205050 EUR za Španijo;
EUR 529615 for France;
529615 EUR za Francijo;
EUR 521590 for Italy;
521590 EUR za Italijo;
EUR 147375 for Latvia;
147375 EUR za Latvijo;
EUR 92123 for Lithuania;
92123 EUR za Litvo;
EUR 98893 for Hungary;
98893 EUR za Madžarsko;
EUR 254108 for Poland;
254108 EUR za Poljsko;
EUR 28020 for Portugal;
28020 EUR za Portugalsko;
EUR 183337 for Slovakia;
183337 EUR za Slovaško;
EUR 213986 for Finland;
213986 EUR za Finsko;
EUR 39862 for Sweden;
39862 EUR za Švedsko;
EUR 267482 for the United Kingdom.
267482 EUR za Združeno kraljestvo;
shall not exceed EUR 595 per visit of an apiary.
ne presega 595 EUR na obisk čebelnjaka.
The maximum overall contribution authorised by this Decision for the costs incurred for the programmes referred to in Article 1 is set at EUR 3307803 to be financed from the general budget of the European Union.
Skupni najvišji prispevek, odobren s tem sklepom, za stroške programov iz člena 1, v višini 3307803 EUR se financira iz splošnega proračuna Evropske unije.
Expenditure relating to staff costs for performing laboratory tests, sampling, monitoring, consumables and overheads dedicated to the surveillance studies shall be eligible in accordance with the rules set out in Annex III.
Izdatki, ki se nanašajo na stroške zaposlenih za laboratorijske preiskave, vzorčenje, nadzor, potrošni material in splošni stroški v okviru študij spremljanja, so upravičeni v skladu s pravili, določenimi v Prilogi III.
The Union’s financial assistance shall be paid following presentation and approval of the reports and supporting documents referred to Article 3(2) and (3).
Finančna pomoč Unije se plača po predložitvi in odobritvi poročil ter dokazilnih listin iz člena 3(2) in (3).
The programmes shall be carried out in accordance with the technical document ‘Basis for a pilot surveillance project on honey bee colony losses’ (available at http://ec.europa.eu/food/animal/liveanimals/bees/bee_health_en.htm) and in accordance with the surveillance study programmes on honeybee colony losses presented by the Member States.
Programi se izvajajo v skladu s tehničnim dokumentom „Osnova za poskusni nadzorni projekt o izgubi čebeljih kolonij“ (na voljo na http://ec.europa.eu/food/animal/liveanimals/bees/bee_health_en.htm) in v skladu s programi študij spremljanja izgub čebeljih kolonij, ki so jih predložile države članice.
Belgium, Denmark, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Hungary, Poland, Portugal, Slovakia, Finland, Sweden and the United Kingdom shall submit to the Commission:
Belgija, Danska, Nemčija, Estonija, Grčija, Španija, Francija, Italija, Latvija, Litva, Madžarska, Poljska, Portugalska, Slovaška, Finska, Švedska in Združeno kraljestvo predložijo Komisiji:
no later than 1 March 2013 an intermediate technical report on the first visit provided for in the surveillance study programme, and
najpozneje do 1. marca 2013 vmesno tehnično poročilo o prvem obisku, predvidenem v programu študij spremljanja, in
no later than 31 October 2013 a final technical report on the second and third visits provided for in the surveillance study programme,
najpozneje do 31. oktobra 2013 končno tehnično poročilo o drugem in tretjem obisku, predvidenima v programu študij spremljanja;
the technical report should be in conformity to a model to be established by the Commission in cooperation with the EU reference laboratory for bee health.
tehnično poročilo mora biti v skladu z vzorcem, ki ga določi Komisija v sodelovanju z referenčnim laboratorijem EU za zdravstveno varstvo čebel.
no later than 31 December 2013 a paper version and an electronic version of their financial report drawn up in accordance with Annex II.
najpozneje do 31. decembra 2013 v papirnati in elektronski obliki finančno poročilo, napisano v skladu s Prilogo II.
The outcome of the studies shall be made available to the Commission and the EU reference laboratory for bee health.
Rezultati študij bodo na razpolago Komisiji in referenčnemu laboratoriju EU za zdravstveno varstvo čebel.
This Decision is addressed to the Kingdom of Belgium, the Kingdom of Denmark, the Federal Republic of Germany, the Republic of Estonia, the Hellenic Republic, the Kingdom of Spain, the French Republic, the Italian Republic, the Republic of Latvia, the Republic of Lithuania, Hungary, the Republic of Poland, the Portuguese Republic, the Slovak Republic, the Republic of Finland, the Kingdom of Sweden and the United Kingdom of Great Britain and Northern Ireland.
Ta sklep je naslovljen na Kraljevino Belgijo, Kraljevino Dansko, Zvezno republiko Nemčijo, Republiko Estonijo, Helensko republiko, Kraljevino Španijo, Francosko republiko, Italijansko republiko, Republiko Latvijo, Republiko Litvo, Madžarsko, Republiko Poljsko, Portugalsko republiko, Slovaško republiko, Republiko Finsko, Kraljevino Švedsko in Združeno kraljestvo Velike Britanije in Severne Irske.
Done at Brussels, 4 July 2012.
V Bruslju, 4. julija 2012
COM(2010) 714 final.
COM(2010) 714 final.
OJ L 343, 23.12.2011, p. 119.
UL L 343, 23.12.2011, str. 119.
Number of apiaries
Število čebelnjakov
Number of visits per apiary foreseen in the surveillance study
Število obiskov na čebelnjak, kot je predvideno v študiji spremljanja
Total direct costs
Skupni neposredni stroški
(Laboratory tests + visits for sampling and monitoring)
(laboratorijski testi + obiski za vzorčenje in spremljanje)
Overheads
Splošni stroški
MODEL FOR A FINANCIAL REPORT ON VOLUNTARY SURVEILLANCE STUDIES ON HONEYBEE COLONY LOSSES
VZOREC ZA FINANČNO POROČILO O NEOBVEZNIH ŠTUDIJAH SPREMLJANJA IZGUB KOLONIJ MEDONOSNIH ČEBEL
Total expenditure for the project (real costs, VAT excl.)
Skupni izdatki za projekt (dejanski stroški, brez DDV)
Number of apiaries visited:
Število obiskanih čebelnjakov:
Laboratory costs
Stroški laboratorija
Number of working days
Število delovnih dni
Daily rate
Dnevna tarifa
Consumables (description)
Potrošni material (opis)
Sampling and monitoring costs (apiary visits)
Stroški vzorčenja in spremljanja (obiski čebelnjakov)
the expenditure listed above was incurred in the performance of tasks described in the technical document ‘Basis for a pilot surveillance project on honey bee colony losses’ [1] and directly related to the implementation of the surveillance study programme for which financial support was granted according to Commission Implementing Decision 2012/362/EU,
so zgoraj navedeni izdatki nastali pri opravljanju nalog, opisanih v tehničnem dokumentu „Osnova za poskusni nadzorni projekt o izgubi čebeljih kolonij“ [1] , in so neposredno povezani z izvajanjem programa študij spremljanja, za katerega je bila finančna podpora odobrena v skladu z Izvedbenim sklepom Komisije 2012/362/EU,
the expenditure was actually incurred, accurately accounted for and eligible under the provisions of Implementing Decision 2012/362/EU,
so izdatki dejanski, natančno evidentirani in upravičeni v skladu z določbami iz Izvedbenega sklepa Komisije 2012/362/EU,
all supporting documents relating to the expenditure are available for auditing,
so vse dokazilne listine o teh stroških na voljo za revizijo,
no other Union contribution was requested for the projects listed in this Decision.
za projekte iz tega sklepa ni bilo zaprošeno za noben drug prispevek Unije.
Name and signature of the financial officer responsible:
Ime in podpis pristojnega finančnega uradnika:
Available at http://ec.europa.eu/food/animal/liveanimals/bees/bee_health_en.htm
(na voljo na: http://ec.europa.eu/food/animal/liveanimals/bees/bee_health_en.htm)
ELIGIBILITY RULES
PRAVILA O UPRAVIČENOSTI
Staff costs shall be limited to actual attributable labour costs (remuneration, wages, social charges and retirement costs) accrued in implementation of the study and performing laboratory tests.
Stroški za zaposlene so omejeni na dejanske pripisljive stroške dela (osebni prejemki, plače, prispevki za socialno varnost in pokojninski stroški), nastale pri izvajanju študij in laboratorijskih preiskav.
To this end monthly timesheets have to be maintained.
V ta namen je treba voditi mesečne časovne preglednice.
Daily rate will be calculated on a 220 working days/year.
Dnevne tarife bodo izračunane na podlagi 220 delovnih dni na leto.
Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory.
Stroški za potrošni material bodo povrnjeni na podlagi dejanskih stroškov, ki jih bodo za izvedbo laboratorijskih testov imele države članice.
Test kits, reagents and all consumables shall only be reimbursed if used specifically in the performance of the following tests:
Stroški za komplete za testiranje, reagente in ves potrošni material se povrnejo samo, če se uporabljajo posebej za opravljanje naslednjih testov:
varroa count (washing),
štetje varoj (pranje),
detection and characterisation of deformed wing virus (DWV), the acute bee paralysis virus (ABPV), the small hive beetle (Aethina tumida) and the tropilaelaps mite),
odkrivanje in opredelitev virusa deformiranih kril (deformed wing virus – DWV), virusa akutne paralize čebel (acute bee paralysis virus – ABPV), malega panjskega hrošča (Aethina tumida) in pršic Tropilaelaps,
clinical observation (including symptom observation foulbrood, nosema, viruses) microsporidian parasite (Nosema spp.) spore counts, cultures, microscopic examination and biochemical tests to identify the causal agent European foulbrood (Melissococcus plutonius) and American foulbrood (Paenibacillus larvae),
klinično opazovanje (vključno z opazovanjem simptomov hude gnilobe čebelje zalege, noseme, virusov), štetje spor Nosema spp. (mikrosporidnega parazita), kulture, mikroskopski pregledi in biokemijski testi za ugotavljanje povzročitelja blage gnilobe čebelje zalege (European foulbrood – Melissococcus plutonius) in hude gnilobe čebelje zalege (American Foulbrood – Paenibacillus larvae),
American foulbrood — confirmation of the identity of the causal agent American foulbrood and European foulbrood via polymerase chain reaction (PCR).
huda gniloba čebelje zalege (American foulbrood) – potrditev identitete povzročitelja hude in blage (European foulbrood) gnilobe čebelje zalege z metodo verižne reakcije s polimerazo (Polymerase Chain Reaction – PCR).
Sampling and monitoring costs
Stroški vzorčenja in spremljanja
Costs for sampling and monitoring can only be claimed it they are directly linked to visits of apiaries.
Stroški zaradi vzorčenja in spremljanja se lahko uveljavljajo samo, če so neposredno povezani s pregledi čebelnjakov.
Staff costs shall be limited to actual attributable labour costs (remuneration, wages, social charges and retirement costs) accrued in implementation of the study.
Stroški za zaposlene so omejeni na dejanske pripisljive stroške dela (osebni prejemki, plače, prispevki za socialno varnost in pokojninski stroški), nastale pri izvajanju študij.
Reimbursement of consumables shall be based on actual costs incurred by Member States and shall only be reimbursed if used specifically during visits to the apiaries.
Stroški za potrošni material bodo povrnjeni na podlagi dejanskih stroškov, ki jih imajo države članice, in se povrnejo samo, če so nastali zaradi obiskov čebelnjakov.
A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed.
Zahteva se lahko pavšalni prispevek v višini 7 %, kar je izračunano na podlagi vseh neposrednih upravičenih stroškov.
The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.
Izdatki, ki jih države članice predložijo za finančni prispevek Unije, se izrazijo v eurih ter izključujejo davek na dodano vrednost (DDV) in vse druge davke.
allowing Member States to extend provisional authorisations granted for the new active substances bixafen, Candida oleophila strain O, fluopyram, halosulfuron, potassium iodide, potassium thiocyanate and spirotetramat
o dovoljenju državam članicam za podaljšanje začasnih registracij, odobrenih za nove aktivne snovi biksafen, Candida oleophila, sev O, fluopiram, halosulfuron, kalijev jodid, kalijev tiocianat in spirotetramat
(notified under document C(2012) 4436)
(notificirano pod dokumentarno številko C(2012) 4436)
In accordance with Article 6(2) of Directive 91/414/EEC, in October 2008 the United Kingdom received an application from Bayer CropScience AG for the inclusion of the active substance bixafen in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo oktobra 2008 prejelo zahtevek družbe Bayer CropScience AG za vključitev aktivne snovi biksafen v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2009/700/EC [3] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2009/700/ES [3] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in July 2006 the United Kingdom received an application from Bionext SPRL for the inclusion of the active substance Candida oleophila strain O in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo julija 2006 prejelo zahtevek družbe BIONEXT sprl za vključitev aktivne snovi Candida oleophila, sev O, v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2007/380/EC [4] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2007/380/ES [4] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in June 2008 Germany received an application from Bayer CropScience AG for the inclusion of the active substance fluopyram in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nemčija junija 2008 prejela zahtevek družbe Bayer CropScience AG za vključitev aktivne snovi fluopiram v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2009/464/EC [5] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2009/464/ES [5] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in May 2005 Italy received an application from Nissan Chemical Europe SARL for the inclusion of the active substance halosulfuron in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Italija maja 2005 prejela zahtevek družbe Nissan Chemical Europe SARL za vključitev aktivne snovi halosulfuron v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2006/586/EC [6] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2006/586/ES [6] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in September 2004 the Netherlands received an application from Koppert Beheer BV for the inclusion of the active substance potassium iodide in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska septembra 2004 prejela zahtevek podjetja Koppert Beheer BV za vključitev aktivne snovi kalijev jodid v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2005/751/EC [7] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2005/751/ES [7] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in September 2004 the Netherlands received an application from Koppert Beheer BV for the inclusion of the active substance potassium thiocyanate in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska septembra 2004 prejela zahtevek podjetja Koppert Beheer BV za vključitev aktivne snovi kalijev tiocianat v Prilogo I k Direktivi 91/414/EGS.
Decision 2005/751/EC confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo 2005/751/ES je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in October 2006 Austria received an application from Bayer CropScience AG for the inclusion of the active substance spirotetramat in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Avstrija oktobra 2006 prejela zahtevek družbe Bayer CropScience AG za vključitev aktivne snovi spirotetramat v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2007/560/EC [8] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2007/560/ES [8] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
The rapporteur Member States submitted the respective draft assessment reports to the Commission on 16 December 2009 (bixafen), on 5 February 2008 (Candida oleophila strain O), on 30 August 2011 (fluopyram), on 30 March 2008 (halosulfuron), on 27 July 2007 (potassium iodide and potassium thiocyanate) and on 29 April 2008 (spirotetramat).
Države članice poročevalke so Komisiji predložile zadevne osnutke poročil o oceni 16. decembra 2009 (biksafen), 5. februarja 2008 (Candida oleophila, sev O), 30. avgusta 2011 (fluopiram), 30. marca 2008 (halosulfuron), 27. julija 2007 (kalijev jodid in kalijev tiocianat) in 29. aprila 2008 (spirotetramat).
Therefore, the examination of the dossiers is still ongoing and it will not be possible to complete the evaluation within the time-frame provided for in Directive 91/414/EEC, read in conjunction with Commission Decisions 2010/457/EU [9] (Candida oleophila strain O, potassium iodide and potassium thiocyanate) and 2010/671/EU [10] (spirotetramat).
Zato pregled dokumentacije še vedno poteka, ocene pa ne bo mogoče končati v roku iz Direktive 91/414/EGS, ki se razlaga skupaj s Sklepom Komisije 2010/457/EU [9] (Candida oleophila, sev O, kalijev jodid in kalijev tiocianat) in Sklepom Komisije 2010/671/EU [10] (spirotetramat).
It is expected that the evaluation and decision-making process with respect to a decision on a possible approval in accordance with Article 13(2) of Regulation (EC) No 1107/2009 for bixafen, Candida oleophila strain O, fluopyram, halosulfuron, potassium iodide, potassium thiocyanate and spirotetramat will have been completed within 24 months.
Pričakuje se, da bosta ocenjevanje in postopek odločanja glede odločitve o morebitni odobritvi v skladu s členom 13(2) Uredbe (ES) št. 1107/2009 za aktivne snovi biksafen, Candida oleophila, sev O, fluopiram, halosulfuron, kalijev jodid, kalijev tiocianat in spirotetramat končana v 24 mesecih.
Member States may extend provisional authorisations for plant protection products containing bixafen, Candida oleophila strain O, fluopyram, halosulfuron, potassium iodide, potassium thiocyanate or spirotetramat for a period ending on 31 July 2014 at the latest.
Države članice lahko podaljšajo začasne registracije fitofarmacevtskih sredstev, ki vsebujejo aktivne snovi biksafen, Candida oleophila, sev O, fluopiram, halosulfuron, kalijev jodid, kalijev tiocianat ali spirotetramat, najpozneje do 31. julija 2014.
This Decision shall expire on 31 July 2014.
Ta sklep preneha veljati 31. julija 2014.
OJ L 240, 11.9.2009, p. 32.
UL L 240, 11.9.2009, str. 32.
OJ L 151, 16.6.2009, p. 37.
UL L 151, 16.6.2009, str. 37.
OJ L 218, 19.8.2010, p. 24.
UL L 218, 19.8.2010, str. 24.
OJ L 290, 6.11.2010, p. 49.
UL L 290, 6.11.2010, str. 49.
on the position to be taken by the European Union in the EEA Joint Committee concerning an amendment to Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
o stališču Evropske unije v Skupnem odboru EGP v zvezi s spremembo Priloge II (Tehnični predpisi, standardi, preskušanje in certificiranje) k Sporazumu EGP
Having regard to the Treaty on the Functioning of the European Union, and in particular Articles 43(2), 114(1) and 207(2), in conjunction with 218(9) thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti člena 43(2), člena 114(1) in člena 207(2) v povezavi s členom 218(9) Pogodbe,
Regulation (EC) No 764/2008 of the European Parliament and of the Council of 9 July 2008 laying down procedures relating to the application of certain national technical rules to products lawfully marketed in another Member State [2] is to be incorporated into the Agreement on the European Economic Area (‘EEA Agreement’).
Uredbo (ES) št. 764/2008 Evropskega parlamenta in Sveta z dne 9. julija 2008 o določitvi postopkov za uporabo nekaterih nacionalnih tehničnih pravil za proizvode, ki se zakonito tržijo v drugi državi članici [2], je treba vključiti v Sporazum o Evropskem gospodarskem prostoru (v nadaljnjem besedilu: Sporazum EGP).
Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008 setting out the requirements for accreditation and market surveillance relating to the marketing of products [3] is to be incorporated into the EEA Agreement.
Uredbo (ES) št. 765/2008 Evropskega Parlamenta in Sveta z dne 9. julija 2008 o določitvi zahtev za akreditacijo in nadzor trga v zvezi s trženjem proizvodov [3] je treba vključiti v Sporazum EGP.